GW Pharmaceuticals plc Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 74 Posts
1 2 3 ... 5
Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio
Article By: Benzinga Thursday, May 6, 2021 10:52 AM EDT
The biopharmaceutical company Jazz Pharmaceuticals, has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc.
In this article: JAZZ, GWPH
Read
E Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week
Article By: Lorimer Wilson Sunday, April 25, 2021 3:00 AM EDT
Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC.
In this article: GWPH, ZYNE, CRBP, VBIO, RVVTF, CNBX, TBPMF, IMLFF, MGCLF, ZLDAF, ARTL, ENVB
Read
Jazz Pharmaceuticals Buys GW Pharma For $7.2 Billion
Video By: CNBC Wednesday, February 3, 2021 9:39 AM EDT
Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share.
In this video: JAZZ, GWPH
Watch
Netflix Took 10 Years To Accomplish What One Company Could Do In Just 3
Article By: Michael A Robinson Saturday, November 28, 2020 9:21 PM EDT
One billion dollars in annual sales. It’s a milestone for a public company that signifies it’s a winner. Customers will pay anything to use their products and services.
In this article: GWPH Also: AAPL, GOOG, NFLX
Read
E 4 Mental Health Stocks Got My Mind Made Up
Article By: Sunil Tinani Friday, November 13, 2020 4:45 AM EDT
The WHO has urged nations to increase their investment in mental healthcare services, or risk facing an upsurge of cases. Biotech and service companies in the mental healthcare niche are expected to do well in the medium to long term.
In this article: ITCI, ACHC, SUPN, GWPH
Read
Why Shares Of GW Pharmaceuticals Are A Buy For 2021
Article By: StockNews Thursday, November 5, 2020 12:20 PM EDT
GWPH earnings came in at -0.36 and revenues were $137.10 million for the quarter. Revenues were strong, up 50.7% year over year.
In this article: GWPH Also: MJ
Read
EC Why Cannabis Stocks & ETFs Are Soaring
Video By: Neena Mishra Wednesday, November 4, 2020 7:29 AM EDT
Medical use of marijuana is now legal in 33 states and in the District of Columbia, while its recreational use is legal in 11 states and DC. Some more states are expected to legalize marijuana’s recreational use soon.
In this video: CGC, GWPH, CRON, MJ, ACB, YOLO, CNBS, TOKE
Watch
3 Cannabis Price Target Upgrades Investors Need To Know
Article By: Technical420 Thursday, August 13, 2020 8:43 AM EDT
Earnings season has started to heat up and US cannabis companies have been in focus.
In this article: SMG, GWPH, IIPR
Read
3 Cannabis Stocks We Were Right On From The Beginning
Article By: Technical420 Wednesday, August 12, 2020 8:03 AM EDT
During the last decade, the legal cannabis industry has made incredible advancements as countries across the globe have legalized or decriminalized the plant.
In this article: IIPR, SMG, GWPH
Read
7 High-Risk Stocks For Market Gamblers
Article By: Benzinga Saturday, May 30, 2020 6:00 AM EDT
Casinos are just starting to open back up following COVID-19 shutdowns, but it may still be a while before some gamblers are willing to venture back to Vegas or even their local casino.
In this article: GLNG, SINA, GWPH, LX, NXTC, GOSS, TIGO
Read
E Cannabis Central: Only 7 Pot Stocks Now Have Market Caps Above $1B
Article By: Lorimer Wilson Monday, April 6, 2020 8:48 AM EDT
At the height of the cannabis stock frenzy back in March/April of 2019, there were 17 companies out of a total of 319 companies listed on the various stock exchanges with valuations over $1 billion but now there are only 7. Here is the list.
In this article: CGC, GWPH, CRON, CURLF, IIPR, GTBIF, TCNNF
Read
E Cannabis Central: Sector Declined 2.5% On Friday With Only These 9 Non-Penny Pot Stocks Advancing
Article By: Lorimer Wilson Saturday, April 4, 2020 4:47 PM EDT
Today's article identifies the three non-penny pot stocks that advanced by 5% or more on Friday, the 10 stocks that declined by more than 5% and eight of the remaining stocks that warrant mentioning.
In this article: CGC, GWPH, CRON, PYX, ACB, APHA, HEXO, GNLN, XPHYF
Read
3 Major European Cannabis Markets Investors Need To Be Watching
Article By: Technical420 Thursday, February 20, 2020 7:58 AM EDT
During the last year, we have seen a significant shift in the cannabis sector to where the market is considerably more focused on the international opportunity.
In this article: CGC, ACB, GWPH
Read
How Did GW Pharmaceuticals Compare Against Top Hedge Fund Stocks In 2019?
Article By: Insider Monkey Wednesday, January 8, 2020 11:03 AM EDT
GW Pharmaceuticals plc has experienced an increase in hedge fund sentiment lately. GWPH was in 29 hedge funds’ portfolios at the end of the third quarter of 2019.
In this article: GWPH Also: TDC, GHC, CWEN, BJ
Read
Bull Of The Day - GW Pharmaceuticals
Article By: Kevin Cook Thursday, September 19, 2019 10:02 AM EDT
GW Pharma delivered a bigger sales beat for Epidiolex than even the most optimistic analysts were projecting. GWPH crushed the sales number for the treatment of two rare forms of pediatric epilepsy with $68 million vs. consensus of $45M.
In this article: GWPH
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
1 to 16 of 74 Posts
1 2 3 ... 5